A2AR Expression and Immunosuppressive Environment Independent of <i>KRAS</i> and <i>GNAS</i> Mutations in Pseudomyxoma Peritonei

In pseudomyxoma peritonei (PMP), <i>KRAS</i> and <i>GNAS</i> mutations are frequent. We hypothesized that these mutations may contribute to the suppression of antitumor immunity: <i>KRAS</i> may induce GMCSF expression, while <i>GNAS</i> may enhance the expression of cyclic adenosine monophosphate a...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Shigeki Kusamura, Adele Busico, Elena Conca, Iolanda Capone, Luca Agnelli, Daniele Lorenzini, Silvia Brich, Marta Angelini, Chiara Costanza Volpi, Desirè Viola Trupia, Vincenzo Lagano, Tommaso Torelli, Annunziata Gloghini, Dario Baratti, Marcello Guaglio, Massimo Milione, Marcello Deraco, Federica Perrone
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2023-07-01
Saila:	Biomedicines
Gaiak:	pseudomyxoma peritonei A2AR CD39 CD73 PDL-1
Sarrera elektronikoa:	https://www.mdpi.com/2227-9059/11/7/2049
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!